Thyroid No Surgery for Small Thyroid Cancers: Radiofrequency Ablation is Even Treating Thyroid Cancers.

Thyroid No Surgery for Small Thyroid Cancers: Radiofrequency Ablation is Even Treating Thyroid Cancers.

Thyroid No Surgery for Small Thyroid Cancers: Radiofrequency Ablation is Even Treating Thyroid Cancers.
No Rush to Judgement that you need surgery or long term observation when there is a treatment that can ablate the small cancer with high likelihood you wont need surgery and not have to follow strict neck ultrasound protocol ( active surveillance ) for the rest of your life.
Small papillary cancer in a normal thyroid gland.
Why remove half or all your thyroid for this?
Why keep the cancer in your neck and get neck ultrasounds
 for years under Active Surveillance protocol?
Dr.Guttler’s Comments:
1. Another reason to be evaluated for possible alternative treatment for micro-papillary cancers PTMC <15 mm instead of surgery or long term observation.
2. 503 PTMC in 9 studies were treated with RFA.
3. No patient had local recurrence in followup.
4. 2/503 ( 0.4%) had lymph node metastasis.
5. 1/503 (0.2% ) had a new PTMC treated with RFA.
6. 5/503 (1.1% ) had delayed surgery. 2 with lymph nodes and 3 with unknown etiology.
7. Thermal ablation is an excellent local tumor control method in patients with low-risk PTMCs.
8.Strict inclusion criteria and technical expertise are required to obtain favorable results.
9. Call me for a consultation before you sign up for surgery or Active Surveillance.
       310393-8860 or [email protected]
       Ask for Alicia.
                                                       Dr.G.

Background: Although clinical studies indicate that thermal ablation is effective in treating low-risk papillary thyroid microcarcinomas (PTMCs), the effectiveness of this treatment in patients with low-risk PTMC has not yet been systematically evaluated.

Methods: Ovid-MEDLINE and EMBASE databases were searched for studies published through May 1, 2019, which report the efficacy of thermal ablation in patients with low-risk PTMCs. Data were extracted and methodological quality was assessed independently by two radiologists according to PRISMA guidelines.

Results: This systematic review identified 503 low-risk PTMCs in 470 patients treated by thermal ablation from 9 studies. During follow-up, no patient experienced local tumor recurrence or distant metastasis, whereas two patients (0.4%) experienced lymph node (LN) metastasis. One patient (0.2%) developed a new PTMC, which was successfully treated by additional ablation. Five patients (1.1%) underwent delayed surgery after ablation, including the two patients with LN metastasis and three additional patients with unknown etiology.

Conclusions: Thermal ablation is an excellent local tumor control method in patients with low-risk PTMCs. Strict inclusion criteria and technical expertise are required to obtain favorable results.

Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860